Current mathematical models for analyzing anti-malarial antibody data with an eye to malaria elimination and eradication

Journal of Immunology Research

Volumn 2015, Issue , 2015, Pages

  Sepúlveda, Nuno ^a,b   Stresman, Gillian ^a   White, Michael T ^c,d,e   Drakeley, Chris J ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b UNIVERSITY OF LISBON   (Portugal)

^c MEDICAL RESEARCH COUNCIL   (United Kingdom)

^d WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^e UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; MALARIA VACCINE; PROTOZOON ANTIBODY;

ANIMAL; BRAZIL; EQUATORIAL GUINEA; HUMAN; IMMUNOLOGY; IMMUNOTHERAPY; INFORMATION PROCESSING; KENYA; MALARIA; PLASMODIUM; THEORETICAL MODEL;

ANIMALS; ANTIBODIES, PROTOZOAN; ANTIMALARIALS; BRAZIL; DATASETS AS TOPIC; EQUATORIAL GUINEA; HUMANS; IMMUNOTHERAPY; KENYA; MALARIA; MALARIA VACCINES; MODELS, THEORETICAL; PLASMODIUM;

EID: 84952365270     PISSN: 23148861     EISSN: 23147156     Source Type: Journal    
DOI: 10.1155/2015/738030     Document Type: Review

References (59)

1. World Health Organization (WHO), World Malaria Report 2014, WorldHealth Organization (WHO), Geneva, Switzerland, 2014.
2. R. G. A. Feachem, A. A. Phillips, J. Hwang, et al., "Shrinking the malaria map: progress and prospects," The Lancet, vol. 376, no. 9752, pp. 1566-1578, 2010.
3. N. D. Karunaweera, G. N. Galappaththy, and D. F. Wirth, "On the road to eliminatemalaria in Sri Lanka: lessons fromhistory, challenges, gaps in knowledge and research needs," Malaria Journal, vol. 13, no. 1, article 59, 2014.
4. S. Herrera, S. A. Ochoa-Orozco, I. J. Gonzalez, L. Peinado, M. L. Quinones, and M. Arevalo-Herrera, "Prospects for malaria elimination in mesoamerica and hispaniola," PLOS Neglected Tropical Diseases, vol. 9, no. 5, Article ID e0003700, 2015.
5. J. Monteiro Rodriguez, J. O. Guintran, C. Gomes, et al., "Moving to malaria elimination in Cape Verde," Malaria Journal, vol. 11, supplement 1, article O9, 2012.
6. G. Stresman, T. Kobayashi, A. Kamanga, et al., "Malaria research challenges in low prevalence settings," Malaria Journal, vol. 11, article 353, 2012.
7. M. G. Cunha, E. S. Silva, N. Sepulveda, et al., "Serologically defined variations in malaria endemicity in Para state, Brazil," PLoS ONE, vol. 9, no. 11, Article ID 0113357, 2014.
8. T. Bousema, R. M. Youssef, J. Cook, et al., "Serologic markers for detecting malaria in areas of low endemicity, Somalia, 2008," Emerging Infectious Diseases, vol. 16, no. 3, pp. 392-399, 2010.
9. World Health Organization (WHO), Malaria Entomology and Vector Control. Guide for Participants, WHO, Geneva, Switzerland, 2013.
10. M. Service, Mosquito Ecology-Field Sampling Methods, Applied Science Publishers, London, UK, 1976.
11. L. S. Tusting, T. Bousema, D. L. Smith, and C. Drakeley, "Measuring changes in plasmodium falciparum transmission. Precision, accuracy and costs of metrics," Advances in Parasitology, vol. 84, pp. 151-208, 2014.
12. P. Corran, P. Coleman, E. Riley, and C. Drakeley, "Serology: a robust indicator of malaria transmission intensity?" Trends in Parasitology, vol. 23, no. 12, pp. 575-582, 2007.
13. C. J. Drakeley, P. H. Corran, P. G. Coleman, et al., "Estimating medium-and long-term trends in malaria transmission by using serological markers of malaria exposure," Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 14, pp. 5108-5113, 2005.
14. M. T. Bretscher, S. Supargiyono, M. A. Wijayanti, et al., "Measurement of Plasmodium falciparum transmission intensity using serological cohort data from Indonesian schoolchildren," Malaria Journal, vol. 12, article 21, 2013.
15. J. Cook, I. Kleinschmidt, C. Schwabe, et al., "Serological markers suggest heterogeneity of effectiveness of malaria control interventions on Bioko Island, Equatorial Guinea," PLoS ONE, vol. 6, no. 9, Article ID e25137, 2011.
16. J. Cook, H. Reid, J. Iavro, et al., "Using serological measures to monitor changes in malaria transmission in Vanuatu," Malaria Journal, vol. 9, no. 1, article 169, 2010.
17. E. J. Remarque, B. W. Faber, C. H. M. Kocken, and A. W. Thomas, "Apical membrane antigen 1: a malaria vaccine candidate in review," Trends in Parasitology, vol. 24, no. 2, pp. 74-84, 2008.
18. B. W. Faber, S. Younis, E. J. Remarque, et al., "Diversity covering AMA1-MSP119 fusion proteins as malaria vaccines," Infection and Immunity, vol. 81, no. 5, pp. 1479-1490, 2013.
19. P. D. Crompton, M. A. Kayala, B. Traore, et al., "A prospective analysis of the Ab response to Plasmodium falciparum before and after a malaria season by protein microarray," Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 15, pp. 6958-6963, 2010.
20. D. A. Helb, K. K. Tetteh, P. L. Felgner, et al., "Novel serologic biomarkers provide accurate estimates of recent Plasmodium falciparumexposure for individuals and communities," Proceedings of the National Academy of Sciences of the United States of America, vol. 112, no. 32, pp. E4438-E4447, 2015.
21. A. Voller, G. Huldt, C. Thors, and E. Engvall, "New serological test for malaria antibodies," British Medical Journal, vol. 1, no. 5959, pp. 659-661, 1975.
22. T. Bousema, J. Stevenson, A. Baidjoe, et al., "The impact of hotspot-targeted interventions on malaria transmission: study protocol for a cluster-randomized controlled trial," Trials, vol. 14, article 36, 2013.
23. T. Benaglia, D. Chauveau, D. R. Hunter, and D. S. Young, "Mixtools: an R package for analyzing finite mixture models," Journal of Statistical Software, vol. 32, no. 6, pp. 1-29, 2009.
24. S. Bosomprah, "A mathematical model of seropositivity to malaria antigen, allowing seropositivity to be prolonged by exposure," Malaria Journal, vol. 13, article 12, 2014.
25. D. Modiano, A. Chiucchiuini, V. Petrarca, et al., "Humoral response to Plasmodium falciparum Pf155/ring-infected erythrocyte surface antigen and Pf332 in three sympatric ethnic groups of Burkina Faso," The American Journal of TropicalMedicine and Hygiene, vol. 58, no. 2, pp. 220-224, 1998.
26. D. Modiano, V. Petrarca, B. S. Sirima, et al., "Different response to Plasmodium falciparum malaria in west African sympatric ethnic groups," Proceedings of the National Academy of Sciences of the United States of America, vol. 93, no. 23, pp. 13206-13211, 1996.
27. S. Richardson and P. J. Green, "On Bayesian analysis ofmixtures with an unknown number of components," Journal of the Royal Statistical Society, Series B:Methodological, vol. 59, no. 4, pp. 731-792, 1997.
28. Z. Zhang, K. L. Chan, Y. Wu, and C. Chen, "Learning a multivariate Gaussian mixture model with the reversible jump MCMC algorithm," Statistics and Computing, vol. 14, no. 4, pp. 343-355, 2004.
29. P. Vounatsou, T. Smith, and A. F. M. Smith, "Bayesian analysis of two-component mixture distributions applied to estimating malaria attributable fractions," Journal of the Royal Statistical Society C: Applied Statistics, vol. 47, no. 4, pp. 575-587, 1998.
30. J. Qin and D. H. Leung, "A semiparametric two-component compound mixture model and its application to estimating malaria attributable fractions," Biometrics, vol. 61, no. 2, pp. 456-464, 2005.
31. H. Muench, CatalyticModels in Epidemiology, HarvardUniversity Press, Cambridge, Mass, USA, 1959.
32. J. H. Pull and B. Grab, "Asimple epidemiologicalmodel for evaluating the malaria inoculation rate and the risk of infection in infants," Bulletin of theWorld Health Organization, vol. 51, no. 5, pp. 507-516, 1974.
33. A. Bekessy, L. Molineaux, and J. Storey, "Estimation of incidence and recovery rates of Plasmodium falciparumparasitaemia from longitudinal data," Bulletin of the World Health Organization, vol. 54, no. 6, pp. 685-693, 1976.
34. N. Sepulveda and C. J. Drakeley, "Sample size determination for estimating antibody seroconversion rate under stable malaria transmission intensity,"Malaria Journal, vol. 14, article 141, 2015.
35. C. I. Bliss, "The calculation of the dosage-mortality curve," Annals of Applied Biology, vol. 22, no. 1, pp. 134-167, 1935.
36. M. E. von Fricken, T. A. Weppelmann, B. Lam, et al., "Agespecific malaria seroprevalence rates: a cross-sectional analysis of malaria transmission in the Ouest and Sud-Est departments of Haiti," Malaria Journal, vol. 13, article 361, 2014.
37. B. G. Williams and C. Dye, "Maximumlikelihood for parasitologists," Parasitology Today, vol. 10, no. 12, pp. 489-493, 1994.
38. T. Bonnefoix, P. Bonnefoix, P. Verdiel, and J.-J. Sotto, "Fitting limiting dilution experiments with generalized linear models results in a test of the single-hit poisson assumption," Journal of Immunological Methods, vol. 194, no. 2, pp. 113-119, 1996.
39. D. L. Martin, R. Bid, F. Sandi, et al., "Serology for trachoma surveillance after cessation of mass drug administration," PLoS Neglected Tropical Diseases, vol. 9, no. 2, Article ID e0003555, 2015.
40. S. Delgado, R. C. Neyra, V. R. Q. Machaca, et al., "A history of Chagas disease transmission, control, and re-emergence in perirural La Joya, Peru," PLoS Neglected Tropical Diseases, vol. 5, no. 2, article e970, 2011.
41. S. Supargiyono, M. T. Bretscher, M. A. Wijayanti, et al., "Seasonal changes in the antibody responses against Plasmodium falciparum merozoite surface antigens in areas of differing malaria endemicity in Indonesia," Malaria Journal, vol. 12, no. 1, article 444, 2013.
42. A. C. Marques, "Human migration and the spread of malaria in Brazil," Parasitology Today, vol. 3, no. 6, pp. 166-170, 1987.
43. N. M. Bowman, V. Kawai, M. Z. Levy, et al., "Chagas disease transmission in periurban communities of Arequipa, Peru," Clinical Infectious Diseases, vol. 46, no. 12, pp. 1822-1828, 2008.
44. D. J. Spiegelhalter, N. G. Best, B. P. Carlin, and A. van der Linde, "Bayesian measures of model complexity and fit (with discussion)," Journal of the Royal Statistical Society Series B, vol. 64, no. 4, Article ID 583639, pp. 583-639, 2002.
45. J. Cook, N. Speybroeck, T. Sochanta, et al., "Sero-epidemiological evaluation of changes in Plasmodium falciparum and Plasmodium vivax transmission patterns over the rainy season in Cambodia," Malaria Journal, vol. 11, article 86, 2012.
46. Brazilian Institute of Geography and Statistics, Census 2010, http://censo2010.ibge.gov.br/en/censo-2010.html.
47. P. McCullagh and J. A. Nelder, Generalized Linear Models, Chapman & Hall, London, UK, 2nd edition, 1989.
48. E. J. Bedrick, R. Christensen, and W. Johnson, "A new perspective on priors for generalized linear models," Journal of the American Statistical Association, vol. 91, no. 436, pp. 1450-1460, 1996.
49. P. H. Garthwaite, J. B. Kadane, and A. O'Hagan, "Statistical methods for eliciting probability distributions," Journal of the American Statistical Association, vol. 100, no. 470, pp. 680-701, 2005.
50. E. Pothin, Modelling antibody responses to malaria blood stage infections: a novel method to estimate malaria transmission intensity from serological data [Ph. D. thesis], Imperial College London, London, UK, 2013.
51. M. T. White, J. T. Griffin, O. Akpogheneta, et al., "Dynamics of the antibody response to Plasmodium falciparum infection in african children," Journal of Infectious Diseases, vol. 210, no. 7, pp. 1115-1122, 2014.
52. X.-H. Zhou and W. Tu, "Comparison of several independent population means when their samples contain log-normal and possibly zero observations," Biometrics, vol. 55, no. 2, pp. 645-651, 1999.
53. L. Tian, "Inferences on the mean of zero-inflated lognormal data: the generalized variable approach," Statistics in Medicine, vol. 24, no. 20, pp. 3223-3232, 2005.
54. N. Li, D. A. Elashoff, W. A. Robbins, and L. Xun, "A hierarchical zero-inflated log-normal model for skewed responses," StatisticalMethods inMedical Research, vol. 20, no. 3, pp. 175-189, 2011.
55. G. J. McLachlan, "On bootstrapping the likelihood ratio test for two component normal mixture model," Applied Statistics, vol. 36, no. 3, pp. 318-324, 1987.
56. Y. Lo, N. R. Mendell, and D. B. Rubin, "Testing the number of components in a normal mixture," Biometrika, vol. 88, no. 3, pp. 767-778, 2001.
57. C. Ochieng, P. Ahenda, A. Y. Vittor, et al., "Seroprevalence of infections with dengue, rift valley fever and chikungunya viruses in Kenya, 2007," PLoS One, vol. 10, no. 7, Article ID e0132645, 2015.
58. F. Lu, J. Li, B. Wang, et al., "Profiling the humoral immune responses to Plasmodium vivax infection and identification of candidate immunogenic rhoptry-associatedmembrane antigen (RAMA)," Journal of Proteomics, vol. 102, pp. 66-82, 2014.
59. N. Imai, I. Dorigatti, S. Cauchemez, N. M. Ferguson, and S. I. Hay, "Estimating dengue transmission intensity from seroprevalence surveys in multiple countries," PLoS Neglected Tropical Diseases, vol. 9, no. 4, Article ID e0003719, 2015.